Medicine News and Research

RSS

CPAP reduces nightmare frequency, motivates treatment compliance in patients with PTSD and OSA

A new study suggests that CPAP therapy reduces nightmares in veterans with post-traumatic stress disorder (PTSD) and obstructive sleep apnea (OSA).

9 Jul 2013

Penumbra announces launch of 5MAX ACE device for acute ischemic stroke treatment

Today, Penumbra, Inc. announced the launch and wide availability of the 5MAX ACE, a next generation clot extraction device that uses aspiration alone to engage and remove blood clots causing an acute ischemic stroke.

8 Jul 2013

USMD Holdings extends patient-centric medical care to Alaska

USMD Holdings, Inc. announced today it is extending high-quality, patient-centric medical care to the 49th state by partnering with the Alaska Institute of Surgical & Medical Specialties in Anchorage.

8 Jul 2013

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942.

8 Jul 2013

Adverse fetal growth, exposure to maternal smoking correlated with lower measures of sperm quality

Studies over the past 20 years have suggested (though not unequivocally confirmed) that semen quality is in decline, reflected most evidently in falling sperm counts and reduced sperm motility.

8 Jul 2013

Capricor to become wholly-owned subsidiary of Nile Therapeutics

Capricor, Inc., a privately held biotechnology company developing cardiac stem cell therapeutics to repair damaged heart muscle, and Nile Therapeutics, Inc. announced today that they have entered into a Merger Agreement under which Capricor will become a wholly-owned subsidiary of Nile Therapeutics, Inc. in an all-stock transaction.

8 Jul 2013

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

8 Jul 2013

Study: ChemoFx chemoresponse assay can help identify platinum resistance in primary ovarian cancer

Precision Therapeutics, a leading life-science company dedicated to the improvement of patient outcomes in personalized medicine, today announced findings that support the ChemoFx chemoresponse assay as a tool to aid in the identification of platinum resistance in primary ovarian cancer, according to a presentation at the Annual Meeting of The Western Association of Gynecologic Oncologists June 26-29, in Seattle, Washington.

8 Jul 2013

New study provides data that could help break the cycle of gun violence

They're young. They've been injured in an assault - so badly they went to the emergency room. And nearly one in four of them has a gun, probably an illegal one. What happens next?

8 Jul 2013

Radiologists must become gatekeepers of medical imaging, says Penn Medicine's Saurabh Jha

Big changes are coming to the US health care system—some in response to the mounting scrutiny of medical imaging. New task force recommendations, the Choosing Wisely campaign, and Affordable Care Act policies are all attempting to curtail overtesting—with CT scans, MRIs and any other screening often ordered unnecessarily—that can drive up medical costs, lead to waste and unnecessary radiation, and prompt undue anxiety about false positive results.

6 Jul 2013

Alzheimer's Association upset with CMS draft decision on brain amyloid imaging

The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services draft coverage decision on brain amyloid imaging, particularly given the clear, scientific consensus recommendations provided to CMS by the Association and the Society for Nuclear Medicine and Molecular Imaging regarding appropriate, limited coverage, only in specific populations.

6 Jul 2013

Continental Who's Who recognizes Douglas M. Weissman as a Pinnacle Professional

Dr. Douglas M. Weissman, MD, FACP is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine. As a gastroenterologist in private practice since 1993, Dr. Weissman specializes in the treatment of all gastrointestinal, biliary and liver disease problems.

6 Jul 2013

Researchers develop new PET tracer to better monitor the progress of cancer and cancer therapy

Imaging techniques in cancer medicine provide far more than merely information on the scale and location of cancerous ulcers. There are modern methods that additionally characterise the tumour cells precisely, for instance by specific molecules they carry on their surface. Such additional information gives doctors key clues as to the precise cancer type and enables them to predict the probability that a patient will respond to a particular form of therapy.

6 Jul 2013

S.M. Rezaian says that the spine degrades following inadequate treatment

S.M. Rezaian, MD, FRCS, FICS, PhD has treated well over 13,000 patients throughout his illustrious career in orthopedic medicine. He's truly been an innovator in the field, creating the Rezaian Spinal Fixator and applying minimally-invasive laser back surgery both of which allow for more comprehensive and less risky surgical treatments.

6 Jul 2013

Seattle researchers map critical molecules that regulate inflammation during flu infection

The influenza virus' ability to mutate quickly has produced new, emerging strains that make drug discovery more critical than ever. For the first time, researchers at Seattle BioMed, along with collaborators at the University of California, San Diego School of Medicine, St. Jude Children's Research Hospital and the University of Washington, have mapped how critical molecules regulate both the induction and resolution of inflammation during flu infection.

6 Jul 2013

Research shows gene regulatory sequences may have driven the evolution of human limbs

Thousands of sequences that control genes are active in the developing human limb and may have driven the evolution of the human hand and foot, a comparative genomics study led by Yale School of Medicine researchers has found.

5 Jul 2013

El Lilly calls for Medicare coverage of beta-amyloid imaging agents for Alzheimer's disease

Eli Lilly and Company today announced that the Centers for Medicare & Medicaid Services (CMS) has issued a draft decision proposing Coverage with Evidence Development for the use of beta-amyloid positron emission tomography (PET) imaging agents. Beta-amyloid imaging agents are used to evaluate patients with cognitive impairment for Alzheimer's Disease and other causes of cognitive decline.

5 Jul 2013

Immune response to TB bacterium varies between patients of different ethnic origin

The immune response to the bacterium that causes tuberculosis (TB) varies between patients of different ethnic origin, raising important implications for the development of tests to diagnose and monitor treatment for the disease, according to new research published today in the journal PLOS Pathogens.

5 Jul 2013

New study could lead to better and more targeted drugs for arthritis and cancer

The increased risk of heart attack or stroke associated with many arthritis drugs may be avoidable, according to a new international study co-authored by researchers at Imperial College London.

5 Jul 2013

Findings uncover epigenomic modification that occurs during brain formation

Changes in the epigenome, including chemical modifications of DNA, can act as an extra layer of information in the genome, and are thought to play a role in learning and memory, as well as in age-related cognitive decline.

5 Jul 2013

Medicine News and Research

CPAP reduces nightmare frequency, motivates treatment compliance in patients with PTSD and OSA

Penumbra announces launch of 5MAX ACE device for acute ischemic stroke treatment

USMD Holdings extends patient-centric medical care to Alaska

Soligenix announces personalized medicine collaboration with SciClone

Adverse fetal growth, exposure to maternal smoking correlated with lower measures of sperm quality

Capricor to become wholly-owned subsidiary of Nile Therapeutics

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

Study: ChemoFx chemoresponse assay can help identify platinum resistance in primary ovarian cancer

New study provides data that could help break the cycle of gun violence

Radiologists must become gatekeepers of medical imaging, says Penn Medicine's Saurabh Jha

Alzheimer's Association upset with CMS draft decision on brain amyloid imaging

Continental Who's Who recognizes Douglas M. Weissman as a Pinnacle Professional

Researchers develop new PET tracer to better monitor the progress of cancer and cancer therapy

S.M. Rezaian says that the spine degrades following inadequate treatment

Seattle researchers map critical molecules that regulate inflammation during flu infection

Research shows gene regulatory sequences may have driven the evolution of human limbs

El Lilly calls for Medicare coverage of beta-amyloid imaging agents for Alzheimer's disease

Immune response to TB bacterium varies between patients of different ethnic origin

New study could lead to better and more targeted drugs for arthritis and cancer

Findings uncover epigenomic modification that occurs during brain formation

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News